Drug Profile
Research programme: diabetes therapy - Bexel
Alternative Names: BLX-1117Latest Information Update: 05 Sep 2007
Price :
$50
*
At a glance
- Originator BEXEL Pharmaceuticals
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Type 2 diabetes mellitus